Marie Kosco-Vilbois, PhD, has extensive experience in the biopharmaceutical industry and has served as chief scientific officer for AC Immune since 2019. From 2002 to 2018, she held senior roles at Novimmune, including chief scientific officer. Prior to joining Novimmune, Dr. Kosco-Vilbois was head of immunology and preclinical pharmacology at the Serono Pharmaceutical Research Institute, a senior scientist and then head of immunology at the Glaxo Wellcome Research Institute in Geneva, and a scientific member of the Basel Institute for Immunology. During her career, she has taken numerous biologicals from discovery into pre-clinical studies and clinical development, most notably filing market applications of a biological for an orphan indication.

Dr. Kosco-Vilbois earned a bachelor’s degree in biology from Rutgers University and a doctorate in anatomy and immunology from Virginia Commonwealth University School of Medicine.